COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

February 23, 2021
Preprint
Open Access

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

BioRxiv : the Preprint Server for Biology
S. NambulliP. W. Duprex
February 23, 2021
Preprint
Open Access

Metagenomic diagnosis and pathogenic network profile of SARS-CoV-2 in patients co-morbidly affected by type 2 diabetes

BioRxiv : the Preprint Server for Biology
H. M. Al-EmranMd. Anwar Hossain
February 23, 2021
Preprint
Open Access

Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection

BioRxiv : the Preprint Server for Biology
D. BottinoArijit Chakravarty
February 23, 2021
Preprint
Open Access

Structural Basis for SARS-CoV-2 Envelope Protein in Recognition of Human Cell Junction Protein PALS1

BioRxiv : the Preprint Server for Biology
J. ChaiQun Liu
February 23, 2021
Preprint
Open Access

Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.

BioRxiv : the Preprint Server for Biology
R. GoswamiSallie R. Permar
February 23, 2021
Preprint
Open Access

Comprehensive evaluation of ACE2 expression in female ovary by single-cell RNA-seq analysis

BioRxiv : the Preprint Server for Biology
Siming KongJ. Qiao
February 19, 2021
Preprint

Epidemic spreading under pathogen evolution

ArXiv
Xiyun ZhangBaruch Barzel
February 21, 2021
Preprint

Policy-Aware Mobility Model Explains the Growth of COVID-19 in Cities

ArXiv
Zhenyu HanJames A. Evans
February 21, 2021
Preprint

Estimating SARS-CoV-2 Infections from Deaths, Confirmed Cases, Tests, and Random Surveys

ArXiv
Nicholas J. Irons, Adrian E. Raftery
February 24, 2021
Open Access

Mainstreaming of Health Equity in Infectious Disease Control Policy During the COVID-19 Pandemic Era.

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Hongjo ChoiWorking Group for the People’s Report on COVID-19 in Korea
February 24, 2021
Open Access

COVID-19 International Collaborative Research by the Health Insurance Review and Assessment Service Using Its Nationwide Real-world Data: Database, Outcomes, and Implications.

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Yeunsook RhoJin Yong Lee
February 24, 2021
Open Access

Particle Filtration Efficiency Testing of Sterilization Wrap Masks.

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Destiny F ChauMichael L Schmitz
February 24, 2021
Open Access

An Observational Study in Manipur State, India on Preventive Behavior Influenced by Social Media During the COVID-19 Pandemic Mediated by Cyberchondria and Information Overload.

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Renu BalaCh Lily Anal
February 24, 2021
Open Access

New Obligations of Health Insurance Review and Assessment Service: Taking Full-fledged Action Against the COVID-19 Pandemic.

Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi
Seung Mi YooSun Min Kim
February 24, 2021

Differences between sexes concerning COVID-19-related pneumonia.

Panminerva Medica
Paolo BanfiAntonello Nicolini
February 24, 2021
Open Access

Potential therapeutic road for targeting the SARS-CoV-2 at throat.

Bratislavské lekárske listy
M KayaS Ozturk

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

© 2021 Meta ULC. All rights reserved
/feed-previews/covid-19/af84352b-285c-4b73-9254-41610da4413b